Thursday, June 6, 2013

• Gencaro™ Potential Efficacy in Preventing Atrial Fibrillation Paper Published in JACC: Heart FailureBusiness Wire( (Thu, Jun 6)

Wednesday, June 5, 2013

• ARCA biopharma Announces Closing of $20 Million Equity OfferingBusiness Wire( (Wed, Jun 5)

Thursday, May 30, 2013

• ARCA biopharma Announces Pricing of $20 Million Equity OfferingBusiness Wire( (Thu, May 30)

Monday, May 6, 2013

• ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic LeaderBusiness Wire( (Mon, May 6)

Monday, April 22, 2013

• ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTMBusiness Wire( (Mon, Apr 22)

Friday, March 8, 2013

• CEO of ARCA biopharma to Speak on Changing Paradigms in Drug Development at ACC.13 Conference on March 10, 2013Business Wire( (Fri, Mar 8)

Tuesday, March 5, 2013

• ARCA biopharma, Inc. Announces Reverse Stock SplitBusiness Wire( (Tue, Mar 5)

Wednesday, February 6, 2013

• Unmet Medical Need in Treatment of Heart Failure Patients with Atrial Fibrillation Highlighted in Articles in Inaugural Issue of JACC: Heart FailureBusiness Wire( (Wed, Feb 6)

Friday, February 1, 2013

• Biotech Companies Attractive Targets for Pharma Companies Looking to Replace Lost RevenuesMarketwired( (Fri, Feb 1)

Tuesday, January 29, 2013

• New Adaptive Phase 3 Trial Planned for GencaroTM in Atrial FibrillationBusiness Wire( (Tue, Jan 29)

Thursday, January 3, 2013

• GencaroTM Effect on Reducing Ventricular Arrhythmias Paper Published in Circulation: Arrhythmia and ElectrophysiologyBusiness Wire( (Thu, Jan 3)

Wednesday, December 12, 2012

• CORRECTING AND REPLACING GencaroTM Cardiovascular Effect on Patients with Atrial Fibrillation Paper Published in European Journal of Heart FailureBusiness Wire( (Wed, Dec 12)